b:{"metadata":[["$","title","0",{"children":"KUNVARJI DAILY EQUITY RESEARCH CONFERENCE_01.11.2021 - Listen Free | WowFM"}],["$","meta","1",{"name":"description","content":"

Equity: GSK Pharma, VIP GAIL

Derivative: USL 950 CE

\n\n--- \n\nSend in a voice message: https://anchor.fm/kunvarji-finstock/message"}],["$","meta","2",{"name":"author","content":"WowFM"}],["$","meta","3",{"name":"keywords","content":"KUNVARJI DAILY EQUITY RESEARCH CONFERENCE_01.11.2021, News, audio, sound, WowFM"}],["$","meta","4",{"name":"creator","content":"WowFM"}],["$","meta","5",{"name":"robots","content":"index, follow"}],["$","meta","6",{"name":"googlebot","content":"index, follow, max-video-preview:-1, max-image-preview:large, max-snippet:-1"}],["$","link","7",{"rel":"canonical","href":"https://www.wowfm.app/sound-detail/kunvarji-daily-equity-research-conference_01-11-2021-23VxWWuPaU1"}],["$","link","8",{"rel":"alternate","hrefLang":"x-default","href":"https://www.wowfm.app/sound-detail/kunvarji-daily-equity-research-conference_01-11-2021-23VxWWuPaU1"}],["$","link","9",{"rel":"alternate","hrefLang":"en-US","href":"https://www.wowfm.app/sound-detail/kunvarji-daily-equity-research-conference_01-11-2021-23VxWWuPaU1"}],["$","link","10",{"rel":"alternate","hrefLang":"ar-SA","href":"https://www.wowfm.app/ar/sound-detail/kunvarji-daily-equity-research-conference_01-11-2021-23VxWWuPaU1"}],["$","link","11",{"rel":"alternate","hrefLang":"fr-FR","href":"https://www.wowfm.app/fr/sound-detail/kunvarji-daily-equity-research-conference_01-11-2021-23VxWWuPaU1"}],["$","link","12",{"rel":"alternate","hrefLang":"id-ID","href":"https://www.wowfm.app/id/sound-detail/kunvarji-daily-equity-research-conference_01-11-2021-23VxWWuPaU1"}],["$","link","13",{"rel":"alternate","hrefLang":"hi-IN","href":"https://www.wowfm.app/hi/sound-detail/kunvarji-daily-equity-research-conference_01-11-2021-23VxWWuPaU1"}],["$","link","14",{"rel":"alternate","hrefLang":"ur-PK","href":"https://www.wowfm.app/ur/sound-detail/kunvarji-daily-equity-research-conference_01-11-2021-23VxWWuPaU1"}],["$","link","15",{"rel":"alternate","hrefLang":"fil-PH","href":"https://www.wowfm.app/fil/sound-detail/kunvarji-daily-equity-research-conference_01-11-2021-23VxWWuPaU1"}],["$","link","16",{"rel":"alternate","hrefLang":"ru-RU","href":"https://www.wowfm.app/ru/sound-detail/kunvarji-daily-equity-research-conference_01-11-2021-23VxWWuPaU1"}],["$","meta","17",{"property":"og:title","content":"KUNVARJI DAILY EQUITY RESEARCH CONFERENCE_01.11.2021 - Listen Free | WowFM"}],["$","meta","18",{"property":"og:description","content":"

Equity: GSK Pharma, VIP GAIL

Derivative: USL 950 CE

\n\n--- \n\nSend in a voice message: https://anchor.fm/kunvarji-finstock/message"}],["$","meta","19",{"property":"og:url","content":"https://www.wowfm.app/sound-detail/kunvarji-daily-equity-research-conference_01-11-2021-23VxWWuPaU1"}],["$","meta","20",{"property":"og:site_name","content":"WowFM"}],["$","meta","21",{"property":"og:locale","content":"en_US"}],["$","meta","22",{"property":"og:image","content":"https://pbcdn.aoneroom.com/image/2025/10/10/889147e9dd0acc66fc369e33b0903590.jpg"}],["$","meta","23",{"property":"og:image:width","content":"1200"}],["$","meta","24",{"property":"og:image:height","content":"630"}],["$","meta","25",{"property":"og:image:alt","content":"WowFM - Premium Audio Content"}],["$","meta","26",{"property":"og:type","content":"website"}],["$","meta","27",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","28",{"name":"twitter:title","content":"KUNVARJI DAILY EQUITY RESEARCH CONFERENCE_01.11.2021 - Listen Free | WowFM"}],["$","meta","29",{"name":"twitter:description","content":"

Equity: GSK Pharma, VIP GAIL

Derivative: USL 950 CE

\n\n--- \n\nSend in a voice message: https://anchor.fm/kunvarji-finstock/message"}],["$","meta","30",{"name":"twitter:image","content":"https://pbcdn.aoneroom.com/image/2025/10/10/889147e9dd0acc66fc369e33b0903590.jpg"}],"$L48","$L49","$L4a"],"error":null,"digest":"$undefined"}

KUNVARJI DAILY EQUITY RESEARCH CONFERENCE_01.11.2021

Description

Uploader

Episodes